Aiming at these existing problems, this study systematically optimized N-benzylaniline-based ALDH2 activators based on their binding mode with ALDH2, obtained water-soluble derivatives, and evaluated their ALDH2 activation activity, as well as their protective effect on animal models of cerebral infarction under conventional injection methods. This evidence concerns the gene ALDH2 and brain infarction.